Found: 7
Select item for more details and to access through your institution.
Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy.
- Published in:
- Arthritis Research & Therapy, 2013, v. 15, n. 5, p. 1, doi. 10.1186/ar4318
- By:
- Publication type:
- Article
Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Two-Year Safety and Effectiveness of Peficitinib in Moderate-To-Severe Rheumatoid Arthritis: A Phase IIb, Open-Label Extension Study.
- Published in:
- Rheumatology & Therapy, 2019, v. 6, n. 4, p. 503, doi. 10.1007/s40744-019-00167-6
- By:
- Publication type:
- Article
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 306, n. 7, p. 711, doi. 10.1001/jama.2011.1169
- By:
- Publication type:
- Article
Tuberculosis latente en el paciente con enfermedad reumática inflamatoria: ¿diferente o ignorada?
- Published in:
- Revista Médica MD, 2016, v. 7, n. 3, p. 120
- By:
- Publication type:
- Article
Tuberculosis latente en el paciente con enfermedad reumática inflamatoria: ¿diferente o ignorada?
- Published in:
- Revista Médica MD, 2016, v. 7, n. 3, p. 120
- By:
- Publication type:
- Article